These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 10192881)
1. Clinical aspects of multiple myeloma and related disorders including amyloidosis. Kyle RA Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881 [TBL] [Abstract][Full Text] [Related]
2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. International Myeloma Working Group Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria of multiple myeloma. Kyle RA Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977 [TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma: diagnosis and treatment. Nau KC; Lewis WD Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734 [TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma: recognition and management. George ED; Sadovsky R Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707 [TBL] [Abstract][Full Text] [Related]
6. 3. The laboratory investigation of monoclonal gammopathies. Kyle RA; Greipp PR Mayo Clin Proc; 1978 Nov; 53(11):719-39. PubMed ID: 101720 [TBL] [Abstract][Full Text] [Related]
7. [Primary amyloidosis associated with kappa light chain myeloma]. Martins RG; Roncon-Albuquerque R; Cabral R; Frazão J; Von Hafe P Acta Med Port; 2010; 23(2):281-4. PubMed ID: 20470479 [TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma: clinical features and indications for therapy. Dispenzieri A; Kyle RA Best Pract Res Clin Haematol; 2005; 18(4):553-68. PubMed ID: 16026737 [TBL] [Abstract][Full Text] [Related]
9. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. Miralles GD; O'Fallon JR; Talley NJ N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle RA; Rajkumar SV Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088 [TBL] [Abstract][Full Text] [Related]
11. The laboratory diagnosis of plasma cell myeloma and related disorders. Nawab RA; Azar HA Orthop Clin North Am; 1979 Apr; 10(2):391-404. PubMed ID: 109804 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders. Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228 [TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system]. Westerhausen M Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157 [TBL] [Abstract][Full Text] [Related]
14. [An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level]. Kanoh T Rinsho Ketsueki; 1996 Dec; 37(12):1416-21. PubMed ID: 8997132 [TBL] [Abstract][Full Text] [Related]
15. [Neurologic sequelae of bone changes in multiple myeloma and its therapy]. Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341 [TBL] [Abstract][Full Text] [Related]
16. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis]. Kanoh T; Yago K; Okuma M Rinsho Ketsueki; 1990 Oct; 31(10):1740-4. PubMed ID: 2255066 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma. Kyle RA Hematol Oncol Clin North Am; 1997 Feb; 11(1):71-87. PubMed ID: 9081205 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathies of undetermined significance. Kyle RA; Rajkumar SV Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745 [TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of measurement of free light chains]. Matsuda M Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770 [TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathies associated with monoclonal proteins: a clinical review. Kelly JJ Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]